Home/Filings/4/0001214659-21-010534
4//SEC Filing

Weiss Patrick 4

Accession 0001214659-21-010534

CIK 0001581280other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 4:35 PM ET

Size

16.7 KB

Accession

0001214659-21-010534

Insider Transaction Report

Form 4
Period: 2021-10-13
Weiss Patrick
VP of Operations
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-10-131,97451,324 total
    Exercise: $26.66Exp: 2028-11-18Common Stock (1,974 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-13$8.82/sh+2,105$18,56651,101 total
  • Exercise/Conversion

    Common Stock

    2021-10-13$25.02/sh+827$20,69253,902 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-10-1382721,513 total
    Exercise: $25.02Exp: 2029-12-09Common Stock (827 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2021-10-132,1050 total
    Exercise: $8.82Exp: 2027-09-28Common Stock (2,105 underlying)
  • Exercise/Conversion

    Common Stock

    2021-10-13$26.66/sh+1,974$52,62753,075 total
  • Sale

    Common Stock

    2021-10-13$104.00/sh4,906$510,22448,996 total
Footnotes (4)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on December 15, 2020.
  • [F2]The option is immediately exercisable. 10% of the shares subject to the option vested on September 28, 2017, 15% of the shares subject to the option vested on September 28, 2018, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  • [F3]20% of the shares subject to the option vested and became exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
  • [F4]25% of the shares subject to the option vested and became exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.

Issuer

Twist Bioscience Corp

CIK 0001581280

Entity typeother

Related Parties

1
  • filerCIK 0001755793

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 4:35 PM ET
Size
16.7 KB